Get the Stockscreener App
381.61
0.08%
-0.30
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $381.61, with a volume of 1.10M.
It is down -0.08% in the last 24 hours and down -2.00% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$381.91
Open:
$382.06
24h Volume:
1.10M
Relative Volume:
0.91
Market Cap:
$145.89B
Revenue:
$23.82B
Net Income/Loss:
$2.92B
P/E Ratio:
50.54
EPS:
7.55
Net Cash Flow:
$4.02B
1W Performance:
+1.31%
1M Performance:
-2.00%
6M Performance:
-1.04%
1Y Performance:
+12.94%
1-Day Range:
$380.57
$382.99
1-Week Range:
$374.52
$383.14
52-Week Range:
$329.16
$406.19
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
381.61 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
ABT
Abbott Laboratories
|
130.27 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.05 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
MDT
Medtronic Plc
|
92.81 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.30 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
How to manage a losing position in Stryker CorporationPortfolio Risk Report & Safe Entry Zone Tips - Newser
Will Stryker Corporation continue its uptrendExit Point & Pattern Based Trade Signal System - Newser
What MACD signals say about Stryker CorporationStop Loss & Accurate Entry/Exit Alerts - Newser
Stryker Insiders Sold US$329m Of Shares Suggesting Hesitancy - 富途牛牛
Stryker (SYK) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
What is the target price for Stryker Corporation stock2025 Trading Recap & Community Driven Trade Alerts - thegnnews.com
Is a relief rally coming for Stryker Corporation holders2025 Pullback Review & Risk Managed Trade Strategies - Newser
Stryker Corporation stock trend forecastGlobal Markets & Daily Chart Pattern Signal Reports - Newser
Is Stryker Corporation a top pick in the sector2025 Valuation Update & Real-Time Volume Analysis Alerts - newsyoung.net
Stryker to host investor day - Yahoo Finance
Stock Analysis | Stryker OutlookA Stock at the Crossroads of Mixed Signals - AInvest
Stryker Navigates 159th Trading Volume Amid Conference Participation and Marginal Stock Decline - AInvest
Stryker's MedSurg President to Share Strategic Updates at Major Healthcare Conference - Stock Titan
Stryker’s SWOT analysis: med device giant’s stock poised for growth - Investing.com
Stryker’s SWOT analysis: med device giant’s stock poised for growth By Investing.com - Investing.com UK
Orthopedic Devices Company Evaluation Report 2024-2025 | Stryker, Zimmer Biomet, and Johnson & Johnson MedTech Lead Across Joint Replacement, Trauma, and Surgical Solutions - Yahoo Finance
5 Revealing Analyst Questions From Stryker’s Q2 Earnings Call - Yahoo Finance
Stryker Edges Lower as 307th in Daily Trading Volume Amid Post-Earnings Consolidation and Digital Health Push - AInvest
Perimeter Announces Preliminary Unaudited Revenues for the 2025 Second Quarter; Reduces Operating Costs by ~30% as Company Focuses on Commercial Sales Pipeline and Growth Opportunities - Benzinga
Stryker (SYK) Announces 5% Increase In Quarterly Dividend To US$0.84 Per Share - Yahoo Finance
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital - Ortho Spine News
Stryker's (NYSE:SYK) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Stryker (SYK): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $407 to $456 - 富途牛牛
Massive Stryker Stock Sale by Director Ronda Stryker! - TipRanks
Stryker Corp To Go Ex-Dividend On September 30th, 2025 With 0.84 USD Dividend Per Share - 富途牛牛
Stryker Corp Director Sells 134,961 Shares Amid Market Volatility - AInvest
Stryker Corp(SYK.US) Director Sells US$75.29 Million in Common Stock - 富途牛牛
Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents - Law360
Berkshire Unit Keeps Win Over Two Stryker Joint-Plate Patents - Bloomberg Law News
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker declares quarterly dividend of $0.84 per share - Investing.com
Stryker raises 2025 sales, earnings guidance again after strong quarter - Crain's Grand Rapids Business
Stryker Corporation (NYSE:SYK) Not Flying Under The Radar - 富途牛牛
Are Medical Stocks Lagging Stryker (SYK) This Year? - Yahoo Finance
What's Driving the Market Sentiment Around Stryker? - 富途牛牛
Truist Financial Keeps Their Hold Rating on Stryker (SYK) - The Globe and Mail
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat - Investing.com Canada
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat By Investing.com - Investing.com South Africa
Fund Update: Mesirow Financial Investment Management, Inc. added 43,487 shares of STRYKER ($SYK) to their portfolio - Quiver Quantitative
Truist Securities raises Stryker stock price target to $415 on solid results By Investing.com - Investing.com South Africa
Truist Securities raises Stryker stock price target to $415 on solid results - Investing.com
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $415 - 富途牛牛
Stryker price target raised to $415 from $410 at Truist - TipRanks
What makes Stryker Corporation stock price move sharplyCapitalize on fast-moving stock opportunities - Jammu Links News
Does Stryker Corporation stock perform well during market downturnsIdentify undervalued stocks poised to rally - Jammu Links News
Why We're Not Concerned About Stryker Corporation's (NYSE:SYK) Share Price - 富途牛牛
Stryker Corporation (NYSE:SYK) Q2 2025 Earnings Call Transcript - Insider Monkey
Stryker Corp Reports Strong Q2 2025 Earnings Growth - The Globe and Mail
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):